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Objective: To evaluate group B streptococcus (GBS) detection in an in vitro setting, using a low and controlled
inoculum from swabs directly inoculated into a selective medium, as compared to delayed inoculation following
a period in a commercial Amies transport medium with charcoal (Venturi Transystem Copan, Italy).
Study design: Clinical isolates of GBS (n = 103), were inoculated into the Amies transport medium with charcoal
in a concentration of 100 colony-forming units (cfu)/ml (10 cfu/swab). Swabs were then transferred to an
enrichment broth (NPC) at time intervals of 0, 2, 4, 6 and 24 hours. Broths were then incubated for 18–24 hours
at35°Cinair,beforebeingtransferredtoNewGranadaMediumModified(NGM)forGBSdetectionandincubated
for a further 18–24 hours at 35°C in air. If the characteristic orange pigmented colonies were observed after
this period, the specimen was recorded as + (1–10 colonies) or ++ (more than 10 colonies).
Results: Overall 92.2% (95/103) of isolates were detected in all tubes and at all times. An additional two isolates
were non-hemolytic, non-pigment forming GBS. Of note, 3.9% (4/103) were negative until 2 hours delayed
inoculation and 1.9% (2/103) gave inconsistent results, likely due to the low inoculum used.
Conclusion: Delayed inoculation into selective enrichment broth following a period in transport medium,
even with a low inoculum, gave a similar and acceptable GBS detection rate to direct inoculation. Hence,
Amies transport medium with charcoal is an appropriate transport medium to use, where it is not practical for
clinical specimens to be directly inoculated into selective enrichment broth and as endorsed in the Centers
for Diseases Control (CDC) Guidelines, 2002.
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Neonatal Group B streptococcus (GBS) sepsis
remains a significant cause of morbidity and
mortality1,2. Although the incidence of perinatal
GBSdisease has declined since the introduction of
intrapartum antibiotic therapy3, it still remains a
leading cause of neonatal GBSdisease 2.I nt h e
prevention strategy of screening pregnant women
for colonization, optimal detection of GBSis
paramount2–6.
To maximize detection rates it is advised that
clinical swabs be taken from both the low vagina
and anorectal region and placed directly into a
GBSselective broth prior to inoculation onto a
selective solid/semi-solid medium2,5. The revised
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 2003 The Parthenon Publishing Group 199CDC guidelines of 2002 recommend the use of a
transport medium such as Amies6. To the best of
our knowledge there is no evidence base for this
recommendation. Further, data are conflicting as
to whether placing the swab into a non-selective
transport medium such as Amies or Stuarts trans-
port medium, prior to inoculation into a selective
enrichment broth, decreases the yield of GBS7,8.
Moreover, selective enrichment broth, which
enhancesGBSgrowth,hasbeenshowntoincrease
GBS detection by up to 50%9.
Other studies evaluating the usefulness of
transport media have provided conflicting infor-
mationinreliablydefiningGBScolonizationrates.
In a clinical-based study conducted in Rhode
Island, USA, Silver and Struminsky8 compared
the collection of two swabs to determine the
difference between direct inoculation into a selec-
tive Todd–Hewitt broth versus delayed inocula-
tion from Stuart’s transport medium. This study
found that compared to direct inoculation onto
selective solid medium, inoculation into selective
broth without delay missed 4.6% of positive GBS
culture results; with delay 16.3% and without
selective broth 31.9% were missed8.
Anotherclinicallybasedstudy,performedinthe
USA by Crisp and co-workers found there was
no statistically significant difference when direct
inoculationintoaselectivemediumwascompared
to delayed inoculation from a standard transport
medium9. However, the time the swab remained
in transport medium was minimal, up to 2 hours9,
and this is not necessarily a practical time period
in clinical practice.
Whereas we at the Women’s and Children’s
Health, Melbourne, Australia once had swabs
inoculated directly into media at the bed side, the
recent merger of the Microbiology services of
the two teaching hospitals to one geographical
site has meant re-evaluation of practices. Of
particular concern were the longer transport
times before inoculation into selective broth for
optimal detection of GBScarriage in pregnant
patients.
As there were no data published to determine
whether placing swabs in transport media for
greater than 2 hours reduced the isolation rate of
GBS, we designed a study to address this, to assist
in changes to our service requirements.
MATERIALS AND METHODS
From stored clinical GBSisolates collected from
routine antenatal screening over the previous 6–8
weeks, 103 were randomly chosen for in vitro
testing. After retrieval of clinical cultures, the GBS
isolates were grown on Horse Blood Agar (HBA)
plates by overnight incubation at 35°C in air. Each
isolate was then suspended in sterile Brain Heart
Infusion (BHI) broth and diluted equivalent to a
0.5 McFarland standard to obtain a concentration
of approximately 1 × 108 cfu/ml.
The prepared inoculum was then diluted
using three 100-fold dilutions to achieve a final
dilution of 100 cfu/ml (10 cfu/swab). This was
performed by adding 25 µl of inoculated broth to
2.5 ml of sterile BHI for each dilution. A viable
count of the final dilution was determined by
culture of 100 µl of the dilution onto an HBA
plate, in duplicate.
Direct inoculation to emulate direct bedside
procedurewasthenperformedbypipetting100 µl
of the final diluted GBSsuspension in BHI onto a
sterile rayon swab and this swab was then placed
immediately into the NPC broth1,3, (a selective
enrichment broth consisting of a Todd–Hewitt
base with selective agents, nalidixic acid, colistin
and crystal violet added) and incubated for
18–24 hours, aerobically at 35°C. This was time
zero. Also at time zero, 100 µl of the final suspen-
sion in BHI was inoculated onto four rayon swabs
which were then placed into Amies transport
medium with charcoal (Venturi Transystem,
Copan, Italy). Swabs were stored in the transport
medium for 2, 4, 6 and 24 hours, after which time
the swabs were removed from the transport
mediumandplacedintoNPCbrothandincubated
for 18–24 hours in air at 35°C.
The swabs from the incubated NPC broths
were then removed and placed into New Granada
Medium Modified (NGM)10 and incubated for
18–24 hours in air at 35°C. The presence of GBS
was detected by the growth of the organism and
the production of the characteristic and specific
orange pigmented colonies in the medium10. The
growth was quantified as negative if there were no
colonies, + if there were 1–10 colonies, and ++ if
there were greater than 10 colonies. All negative
NGMs were subcultured onto solid medium to
confirm negative results.
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Of all the isolates evaluated, 92.2% (95/103) were
positive in all tubes at all time intervals. The
growth in these tubes ranged from + to ++ from
time intervals of 0–24 hours. See Table 1 for a
summaryofresultsofthe103isolates.Attimezero,
3.9% (4/103), were negative but became positive
at either 2 or 4 hours. All four tubes in this group
had ++ growth observed at 24 hours. In addition,
two isolates inoculated gave inconsistent results.
Both of these results are listed in Table 1 and show
tube growth changing from not detected, to + or
++andagaintonotdetected.Anothertwoisolates
were non-hemolytic strains and therefore had no
characteristic orange pigment detected in NGM,
(or very pale observed growth, not characteristic
of the beta-hemolytic strains). This demonstrates
the specificity of the detection medium for
beta-hemolytic strains of GBS, as originally
described in 198611.
DISCUSSION
Consistentlypositiveresultswereobtainedregard-
less of the time delay intervals of 0, 2, 4, 6 and
24 hours and did not make a difference to
the detection rate. In 2.9% of cases the detection
rate improved with delayed inoculation of 2 or
4 hours. Another 1.9% of isolates used gave
inconsistent results; these results are likely
explained by the use of such a low and controlled
inoculum size in the experiment. The non-
hemolyticGBSstrains(1.9%)wouldnothavebeen
detectable in the medium chosen (NGM), as it
relies on pigmentation production, not made by
non-hemolytic streptococci10,11.
In contrast to Silver and co-workers8 we did
find a significant difference in detection of GBS
after many hours in non-nutritive, non-selective
transport medium. However, the results from this
study could have been confounded by the study
design whereby directly inoculated specimens
were compared with those placed into transport
media left in the clinic until the end of the day for
a mean of 9.9 ± 8.5 hours, then plated onto
three different agar media, prior to inoculation
into selective growth medium. This would have
diluted the original inoculum prior to going into
selective medium. Similar to Crisp and co-
workers9 we report no loss of detectability of GBS
when using enrichment broth after swabs have
Group B streptococcus (GBS) screening Teese et al.
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY • 201
Total no.
of isolates
Viable count of inoculum on swab prior
to placement into transport medium
(cfu/ml)
Growth in NGM after time in transport medium
0 hour 2 hours 4 hours 6 hours 24 hours Notes
95
4
2
2
Total
103
6–164
10–32
12–18
8–26
6–164
+/++
N
N
N
N
N (8%)
+/++
(92%)
+/++
N/
+/++
++
N
N/
+
(w)
N (0%)
+(w) (4%)
+/++
(96%)
+/++
+/++
N
+
N
N (3%)
+/++
(97%)
+/++
+/++
++
N
N
N (3%)
+/++
(97%)
+/++
++
++
+
N/
+
(w)
N (0%)
+(w)(2%)
+/++
(98%)
Positive in all tubes,
all times
Positive by 2 or 4 hours
Inconsistent result
number 1
Inconsistent result
number 2
Non-hemolytic
GBS strains
N, no orange pigment observed in New Granada Medium Modified (NGM); +
(w), weak orange pigment observed (not characteristic
orange); +, 1–10 orange colonies observed in NGM; ++, > 10 orange colonies observed in NGM
Table 1 Summary of GBS screening results of swabs from transport media to NGM at specified time intervalsbeen in standard transport media. However, we
were able to show that this was possible for up
to 24 hours in the transport medium and not
just up to 2 hours, as they reported9.
In conclusion, even with such a low inoculum,
passage of GBSthrough Amies transport
medium with charcoal for up to 24 hours prior
to inoculation into the selective enrichment
broth maintains viability and with acceptable
detection rates (98%). At Women’s and
Children’s Health, the collection procedure
change from direct inoculation into NGM to
delayed inoculation into NPC broth and then
NGM has been possible, without any decrease in
GBSdetectionrates.TheswabsinAmiestransport
medium with charcoal provide a good alternative,
where selective enrichment broth cannot be
directly inoculated.
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